Canada markets closed

Evome Medical Technologies Inc. (LNDZF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.1500+0.0176 (+13.29%)
At close: 12:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2100
Open0.1500
Bid0.0012 x 0
Ask0.1500 x 0
Day's Range0.1500 - 0.1500
52 Week Range0.0400 - 0.3150
Volume20,000
Avg. Volume781
Market Cap8.675M
Beta (5Y Monthly)1.88
PE Ratio (TTM)N/A
EPS (TTM)-0.1700
Earnings DateMay 30, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 24, 2017
1y Target EstN/A
  • GlobeNewswire

    Evome Medical Technologies Announces Securities Issuances

    NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the “TSXV”) to complete a shares for services transaction with Beacon Securities Limited (“Beacon”) pursuant to ‎which the Company will issue Beacon ‎504,286 ‎common ‎shares of the Company at a deemed price of ‎$0.1983 per share in satisfaction of $100,000 of advisory services. The shares issuable will be

  • GlobeNewswire

    Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

    NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April and May 2024, the first two months of the second quarter. Mike Seckler, Chief Executive Officer of the Company, will also hold a call to update shareholders on the first quarter financials, second quarter progress and future plans of the Company. Revenue Growth Update for Q2 2024 For April and May 2024,

  • GlobeNewswire

    Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

    Posting Q1 Financials, Provides Updates on Strong Q2NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue at its core business unit, Biodex Medical Systems, Inc. (“Biodex”), while reducing total debt significantly for the third straight quarter. The Company announced it generated 100% revenue growth in its Biodex business unit in April 2024 compared to J